By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Contraceptives > Econtra one-step > Levonorgestrel Dosage
Contraceptives
https://themeditary.com/dosage-information/levonorgestrel-dosage-11461.html

Levonorgestrel Dosage

Drug Detail:Econtra one-step (Levonorgestrel emergency contraceptive [ lee-voe-nor-jes-trel ])

Drug Class: Contraceptives

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Contraception

Intrauterine Device (IUD) insertion should be performed by a trained healthcare provider thoroughly familiar with product; product manufacturer labeling should be consulted:

Insert 1 IUD (13.5, 19.5 or 52 mg) into uterus

Timing of insertion:

  • For women who are not currently using hormonal or intrauterine contraception: Insertion may occur at any time the woman is not pregnant; if inserted after the first 7 days of menstrual cycle, an additional method of contraception should be used for 7 days after insertion
  • Switching from an oral, transdermal, or vaginal hormonal contraceptive: Insertion may occur at any time; if inserted during the hormone phase, continue use for 7 days after insertion or until the end of the current treatment cycle
  • Switching from an injectable progestin contraceptive: Insertion may occur at any time; if inserted more than 3 months after the last injection, an additional method of contraception should be used for 7 days after insertion
  • Switching from a contraceptive implant or another IUD: Insertion should occur on the same day the implant or IUD is removed
  • Inserting after abortion or miscarriage:
  • First trimester: May insert IUD immediately after a first trimester abortion or miscarriage
  • Second trimester: Insertion of IUD should be delayed a minimum of 4 weeks or until the uterus is fully involuted; if involution is delayed, insertion should be delayed until involution is complete; consider the possibility of ovulation and conception occurring prior to insertion and advise patient on need for an additional method of contraception for 7 days after insertion
  • After childbirth: Insertion of IUD should be delayed a minimum of 4 weeks after delivery, or until the uterus is fully involuted; if involution is delayed, insertion should be delayed until involution is complete; consider the possibility of ovulation and conception occurring prior to insertion and advise patient on need for an additional method of contraception for 7 days after insertion

Replacement: IUD should be replaced after the prescribed amount of time; a new IUD may be inserted for continued use
  • Skyla(R): Replace after 3 years
  • Kyleena(R), Mirena(R), and Liletta(R): Replace after 5 years

Comments:
  • IUD may be removed at any time but must be removed by the end of the prescribed time; if continued use is desired, replace with a new IUD.

Uses: Prevention of pregnancy for up to 3 years (Skyla[R]) or 5 years (Kyleena[R], Mirena[R], and Liletta[R]); additionally, Mirena(R) is for the treatment of heavy menstrual bleeding in women who choose to use intrauterine contraception as their method of contraception.

Usual Adult Dose for Postcoital Contraception

Emergency Contraception:

Take 1.5 mg orally once or 0.75 mg orally 12 hours apart

Comments:

  • Doses should be taken as soon as possible within 72 hours after unprotected intercourse or known/suspected contraception failure; the sooner it is taken the better.
  • If vomiting occurs within 2 hours of taking dose, consider repeating the dose.
  • This product is not intended for regular birth control.

Use: To reduce the chance or pregnancy after unprotected intercourse or a known/suspected contraceptive failure.

Usual Pediatric Dose for Contraception

Postpubertal adolescents:
Intrauterine Device (IUD) insertion should be performed by a trained healthcare provider thoroughly familiar with product; product manufacturer labeling should be consulted:

Insert 1 IUD (13.5, 19.5 or 52 mg) into uterus

Timing of insertion:

  • For women who are not currently using hormonal or intrauterine contraception: Insertion may occur at any time the woman is not pregnant; if inserted after the first 7 days of menstrual cycle, an additional method of contraception should be used for 7 days after insertion
  • Switching from an oral, transdermal, or vaginal hormonal contraceptive: Insertion may occur at any time; if inserted during the hormone phase, continue use for 7 days after insertion or until the end of the current treatment cycle
  • Switching from an injectable progestin contraceptive: Insertion may occur at any time; if inserted more than 3 months after the last injection, an additional method of contraception should be used for 7 days after insertion
  • Switching from a contraceptive implant or another IUD: Insertion should occur on the same day the implant or IUD is removed
  • Inserting after abortion or miscarriage:
  • First trimester: May insert IUD immediately after a first trimester abortion or miscarriage
  • Second trimester: Insertion of IUD should be delayed a minimum of 4 weeks or until the uterus is fully involuted; if involution is delayed, insertion should be delayed until involution is complete; consider the possibility of ovulation and conception occurring prior to insertion and advise patient on need for an additional method of contraception for 7 days after insertion
  • After childbirth: Insertion of IUD should be delayed a minimum of 4 weeks after delivery, or until the uterus is fully involuted; if involution is delayed, insertion should be delayed until involution is complete; consider the possibility of ovulation and conception occurring prior to insertion and advise patient on need for an additional method of contraception for 7 days after insertion

Replacement: IUD should be replaced after the prescribed amount of time; a new IUD may be inserted for continued use
  • Skyla(R): Replace after 3 years
  • Kyleena(R), Mirena(R), and Liletta(R): Replace after 5 years

Comments:
  • IUD may be removed at any time but must be removed by the end of the prescribed time; if continued use is desired, replace with a new IUD.

Uses: Prevention of pregnancy for up to 3 years (Skyla[R]) or 5 years (Kyleena[R], Mirena[R], and Liletta[R]); additionally, Mirena(R) is for the treatment of heavy menstrual bleeding in women who choose to use intrauterine contraception as their method of contraception.

Usual Pediatric Dose for Postcoital Contraception

Emergency Contraception:

Postpubertal adolescents:
Take 1.5 mg orally once or 0.75 mg orally 12 hours apart

Comments:

  • Doses should be taken as soon as possible within 72 hours after unprotected intercourse or known/suspected contraception failure; the sooner it is taken the better.
  • If vomiting occurs within 2 hours of taking dose, consider repeating the dose.
  • This product is not intended for regular birth control.

Use: To reduce the chance or pregnancy after unprotected intercourse or a known/suspected contraceptive failure.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Intrauterine Device:

  • Acute liver disease or liver tumor: Contraindicated

Precautions

CONTRAINDICATIONS:

  • Hypersensitivity to the active component or any of the ingredients
  • Known or suspected pregnancy

Intrauterine Device (IUD) is contraindicated if one or more of the following conditions exist:
  • Acute liver disease or liver tumor (benign or malignant)
  • Uterine bleeding of unknown etiology
  • Known or suspected breast cancer or other progestin-sensitive cancer, now or in the past
  • Congenital or acquired uterine anomaly, including fibroids, that distorts uterine cavity and would be incompatible with correct placement
  • Acute pelvic inflammatory disease (PID) or a history of PID unless there has been subsequent intrauterine pregnancy
  • Postpartum endometritis or infected abortion in past 3 months
  • Known or suspected uterine or cervical neoplasia
  • Untreated acute cervicitis or vaginitis, including bacterial vaginosis, known chlamydial or gonococcal cervical infection, or other lower genital tract infections until infection is controlled
  • Conditions associated with increased susceptibility to pelvic infections
  • Use as post-coital contraception
  • A previously inserted intrauterine device that has not been removed

Safety and efficacy have been established in female patients of reproductive age; use prior to menarche is not indicated.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
Emergency Contraception:

  • Take as soon as possible up to 72 hours after unprotected sex; the sooner it is taken the better it will work.
  • If vomiting occur within 2 hours after taking dose, dose should be repeated

Intrauterine Device (IUD):
  • Insertion should be performed by a trained healthcare provider thoroughly familiar with product; product manufacturer labeling should be consulted

Timing of IUD Removal:
  • If pregnancy is desired, the IUD may be removed at any time.
  • If IUD is to be removed and pregnancy is not desired, a new contraception method should be started prior to removal of the IUD.

Storage requirements:
  • IUD: For single use only; store pouch in outer carton until use to protect from light

Monitoring:
  • IUD Follow-up: Re-examine patient 4 to 6 weeks following IUD insertion and once a year thereafter, or more frequently if clinically indicated.
  • Emergency Contraception Follow-up: Physical or pelvic exam is recommended if there is any doubt concerning general health or pregnancy status of any woman after use for postcoital contraception.

Patient advice:
  • Read the US FDA-approved patient labeling (Patient Information).
  • Patients should understand that this drug does not protect against HIV infection and other sexually transmitted infections.
  • Counsel patients on the risks of becoming pregnant if intercourse occurs in the 7-day period after insertion as well as before removal of IUD.
  • Contact healthcare provider promptly if you become pregnant with IUD intact due to the risk of ectopic pregnancy.
  • Report any signs/symptoms of lower abdominal pain, long-lasting or heavy bleeding, painful intercourse, chills, or fever.
  • Report severe pain or fever following IUD insertion due to the risk of infection.

Frequently asked questions

  • Can Plan B make your period late or cause bleeding?
  • Can you drink alcohol after taking Plan B?
  • What's the weight limit for Plan B?
  • How effective is Plan B and how late can you take it?
  • How many times can you take Plan B?
  • Mirena, Kyleena, Skyla & Liletta - What's the difference?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by